A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2)

NCT00550732 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Mycoses

Interventions

DRUG: Posaconazole

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]